ABT — Abbott Laboratories Share News
0.000.00%
Last trade - 00:00- $163.94bn
- $191.33bn
- $44.33bn
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports (updated)
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports
Factbox: Major deals involving US drugmakers and biotechs over the past decade
ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test
Missouri appeals court won't send Abbott's appeal of $495 million preterm baby formula verdict to higher court
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Mead Johnson wins new trial as court reverses $60 million preterm formula verdict (updated)
Mead Johnson wins new trial as court reverses $60 million preterm formula verdict
Brief: Abbott Declares Qtrly Common Dividend Of $0.63 Per Share
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Brief: New Abbott Data Show Many People With Diabetes May Not Recognize Symptoms Of Diabetic Ketoacidosis
Abbott Labs must face lawsuit over PediaSure children's growth claims (updated)
Abbott Labs must face lawsuit over PediaSure children's growth claims
Brief: Insulet Announces U.S. Rollout Of Enhanced Omnipod® 5 Algorithm And Expands Compatibility With Abbott’S Freestyle Libre 3 Plus Sensor
Brief: MiniMed To Expand Sensor Portfolio With Integrated Dual Glucose-Ketone Sensors Made By Abbott
Brief: Abbott Secures CE Mark For Dual Glucose-Ketone Sensing Technology For Diabetes Patients
Brief: Soros Fund Management Reports Share Stake In Mastercard, Berkshire Hathaway & J&J
Brief: Nvision Announced A $55 Million Series B Financing Round Anchored By Abbott
Boston Scientific cuts annual forecast, shares rise on reset (updated)